Elisa Mäkäräinen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Elisa Mäkäräinen has a total of 75 co-authors. Here are the top co-authors by number of shared publications:
Tero Rautio
Oulu University Hospital , Oulu , Finland
7 shared publicationsPasi Ohtonen
Oulu University Hospital , Oulu , Finland
6 shared publicationsAnne K Mattila
Jyväskylä Central Hospital , Gastrointestinal surgery department, Jyväskylä
3 shared publicationsHeikki T Wiik
Oulu University Hospital, Medical Research Centre Oulu , Oulu
3 shared publicationsJyrki Kössi
Division of Surgery, Päijät-Häme Central Hospital, Lahti, Finland
3 shared publicationsLeena-Mari J Mäntymäki
Tampere University Hospital , Gastrointestinal surgery department, Tampere
3 shared publications
Latest Publications
- Open Access
- 19 September 2026
- Published by SAGE Publications in Scandinavian Journal of Surgery
The Nordic parastomal hernia paradox: A regional survey of prophylaxis and repair
Background and aims: To evaluate current preferences and practices as well as institutional policies regarding parastomal hernia (PSH) prevention and repair among Nordic surgeons. Methods: A cross-sectional, web-based survey was distributed to consultant-level surgeons and senior trainees across Denmark, Finland, Norway, and Sweden, assessing demographics, prophylaxis practices, and repair preferences. Results: A total of 191 surgeons responded, of whom 98% practiced in academic or regional hospitals and 50% had >10 years of specialist experience. Among the 166 respondents (87%) who performed permanent end colostomies, only 28% currently used prophylactic mesh, while 53% had never used it, and 19% had discontinued prior use. Prophylactic adoption varied markedly by country: Finland (81%) versus Denmark (0%). Primary barriers were belief in acceptable non-mesh outcomes (42%) and complication fears (40%). Among current mesh users, the intraperitoneal funnel (Chimney) technique was most prevalent (54%). For PSH repair (n = 111), laparoscopic Sugarbaker was the most frequently performed (41%) and preferred (34%) technique. Robotic Pauli emerged as the second most preferred approach (20%), and robotic-assisted repair was used by 17% of repair-performing surgeons, but preferred by 39% of hernia/abdominal wall reconstruction (AWR) specialists. Open surgery was used by 50% but preferred by only 20%, reflecting a marked preference-utilization gap. One-third of respondents (36%) believed more patients should be offered elective PSH repair, with significant country-level variation: 65% of Swedish surgeons favored more repairs, while 42% of Danish surgeons favored fewer repairs. Conclusion: A substantial implementation gap in PSH prophylaxis persists across the Nordic region, driven by surgical culture rather than evidence. In contrast, repair practice is shifting decisively toward robotic retromuscular techniques, led by specialists. The perceived need for more elective repairs, particularly given the high mortality (up to 29%) of emergency repair, supports adopting centralized referral pathways—modeled on the Danish experience—to improve regional outcomes.
- 19 September 2026
- Published by SAGE Publications in Scandinavian Journal of Surgery
Open AccessThe Nordic parastomal hernia paradox: A regional survey of prophylaxis and repair
Background and aims: To evaluate current preferences and practices as well as institutional policies regarding parastomal hernia (PSH) prevention and repair among Nordic surgeons. Methods: A cross-sectional, web-based survey was distributed to consultant-level surgeons and senior trainees across Denmark, Finland, Norway, and Sweden, assessing demographics, prophylaxis practices, and repair preferences. Results: A total of 191 surgeons responded, of whom 98% practiced in academic or regional hospitals and 50% had >10 years of specialist experience. Among the 166 respondents (87%) who performed permanent end colostomies, only 28% currently used prophylactic mesh, while 53% had never used it, and 19% had discontinued prior use. Prophylactic adoption varied markedly by country: Finland (81%) versus Denmark (0%). Primary barriers were belief in acceptable non-mesh outcomes (42%) and complication fears (40%). Among current mesh users, the intraperitoneal funnel (Chimney) technique was most prevalent (54%). For PSH repair (n = 111), laparoscopic Sugarbaker was the most frequently performed (41%) and preferred (34%) technique. Robotic Pauli emerged as the second most preferred approach (20%), and robotic-assisted repair was used by 17% of repair-performing surgeons, but preferred by 39% of hernia/abdominal wall reconstruction (AWR) specialists. Open surgery was used by 50% but preferred by only 20%, reflecting a marked preference-utilization gap. One-third of respondents (36%) believed more patients should be offered elective PSH repair, with significant country-level variation: 65% of Swedish surgeons favored more repairs, while 42% of Danish surgeons favored fewer repairs. Conclusion: A substantial implementation gap in PSH prophylaxis persists across the Nordic region, driven by surgical culture rather than evidence. In contrast, repair practice is shifting decisively toward robotic retromuscular techniques, led by specialists. The perceived need for more elective repairs, particularly given the high mortality (up to 29%) of emergency repair, supports adopting centralized referral pathways—modeled on the Danish experience—to improve regional outcomes.
- Open Access
- 27 November 2025
- Published by Frontiers Media SA in Journal of Abdominal Wall Surgery
- Vol. 4, 15500
Prophylactic Retrorectus Mesh Versus Small-Stitch Closure After Emergency Midline Laparotomy: 2-Year Results of a Randomized Controlled Trial
Introduction: Incisional hernias (IH) are common complications following emergency midline laparotomies. Mesh reinforcement has shown efficacy in preventing incisional hernias in elective surgeries, but evidence remains limited for emergency midline incisions. This study aimed to evaluate the safety and effectiveness of retrorectus placement of a self-gripping polyester mesh in preventing incisional hernia after emergency midline laparotomy, as measured by the incidence of IH, postoperative complications, quality of life, and health economic outcomes. Methods: In this multicenter randomized controlled trial, adult patients undergoing emergency midline laparotomy were randomized to receive either prophylactic retrorectus mesh or standard 4:1 small-stitch fascial closure using a slowly absorbable monofilament suture. The primary outcome was the radiological/clinical IH rate within 2 years after the surgery. Secondary outcomes were complications, reoperations, quality of life, and health-economic measures. Blinding was maintained for patients, outcome assessors, and radiologists. Due to difficulties in recruitment, the study was prematurely terminated prior to reaching the aimed number of patients. Results: Out of 925 patients screened, 109 were randomized, and 72 received the allocated intervention. At 2-year’s follow-up, one (4%) asymptomatic incisional hernia was detected in the control group compared to none in mesh group. In the mesh group, three (9%) patients experienced mesh-related complications: one (5%) retrorectus hematoma, one (5%) internal hernia and one (5%) postoperative seroma. One (5%) additional patient in the mesh group developed a fistula requiring mesh removal. No significant differences were found in early postoperative complications or quality of life between groups. Conclusion: Retrorectus mesh reinforcement did not reduce the incidence of incisional hernia compared to standard small-stitch closure in this trial. However, mesh-related complications were observed. Due to recruitment challenges and limited sample size, definitive conclusions cannot be drawn. Clinical Trial Registration: https://clinicaltrials.gov/study/NCT04311788?term=preemer&rank=1 , NCT04311788.
- 27 November 2025
- Published by Frontiers Media SA in Journal of Abdominal Wall Surgery
- Vol. 4, 15500
Open AccessProphylactic Retrorectus Mesh Versus Small-Stitch Closure After Emergency Midline Laparotomy: 2-Year Results of a Randomized Controlled Trial
Introduction: Incisional hernias (IH) are common complications following emergency midline laparotomies. Mesh reinforcement has shown efficacy in preventing incisional hernias in elective surgeries, but evidence remains limited for emergency midline incisions. This study aimed to evaluate the safety and effectiveness of retrorectus placement of a self-gripping polyester mesh in preventing incisional hernia after emergency midline laparotomy, as measured by the incidence of IH, postoperative complications, quality of life, and health economic outcomes. Methods: In this multicenter randomized controlled trial, adult patients undergoing emergency midline laparotomy were randomized to receive either prophylactic retrorectus mesh or standard 4:1 small-stitch fascial closure using a slowly absorbable monofilament suture. The primary outcome was the radiological/clinical IH rate within 2 years after the surgery. Secondary outcomes were complications, reoperations, quality of life, and health-economic measures. Blinding was maintained for patients, outcome assessors, and radiologists. Due to difficulties in recruitment, the study was prematurely terminated prior to reaching the aimed number of patients. Results: Out of 925 patients screened, 109 were randomized, and 72 received the allocated intervention. At 2-year’s follow-up, one (4%) asymptomatic incisional hernia was detected in the control group compared to none in mesh group. In the mesh group, three (9%) patients experienced mesh-related complications: one (5%) retrorectus hematoma, one (5%) internal hernia and one (5%) postoperative seroma. One (5%) additional patient in the mesh group developed a fistula requiring mesh removal. No significant differences were found in early postoperative complications or quality of life between groups. Conclusion: Retrorectus mesh reinforcement did not reduce the incidence of incisional hernia compared to standard small-stitch closure in this trial. However, mesh-related complications were observed. Due to recruitment challenges and limited sample size, definitive conclusions cannot be drawn. Clinical Trial Registration: https://clinicaltrials.gov/study/NCT04311788?term=preemer&rank=1 , NCT04311788.
- Open Access
- 30 July 2025
- Published by Frontiers Media SA in Journal of Abdominal Wall Surgery
- Vol. 4, 15011
Prophylactic Mesh in Parastomal Hernia Prevention: Current Evidence
Introduction: Parastomal hernia (PSH) is a common long-term complication following stoma creation. The incidence of PSH exceeds 50% in long-term follow-up of end colostomy patients, while it remains lower in ileostomies and ileal conduit urinary diversions. PSH prevention strategies are of interest due to the poor outcomes and high recurrence rates associated with PSH repair.Overview of Techniques to Prevent PSH: Various technical approaches have been explored to reduce the risk of PSH. However, none have shown consistent benefit toward reducing PSH rate without the use of prophylactic mesh. The keyhole mesh technique was the first to demonstrate a significant reduction in PSH rates in early trials, but larger randomized controlled trials (RCTs) have later questioned its efficacy. The modified keyhole technique, using a funnel-shaped mesh, has shown promising results in recent small studies, with lower PSH incidence and potentially reduced stomal prolapse rate. Other methods such as the Sugarbaker technique and use of biological meshes in PSH prevention have been evaluated as well, with mixed results. While most research focuses on end colostomy, there is limited data on PSH prevention in ileostomies and ileal conduits.Conclusion: Despite early enthusiasm, the keyhole technique has not proven to be effective in preventing PSH. The modified funnel-shaped mesh appears to be a promising development, though long-term outcomes are lacking. Preventive mesh placement is still supported by international guidelines; however, these recommendations are not widely followed in colorectal surgery departments. Thus, further research is essential to guide future recommendations for PSH prevention.
- 30 July 2025
- Published by Frontiers Media SA in Journal of Abdominal Wall Surgery
- Vol. 4, 15011
Open AccessProphylactic Mesh in Parastomal Hernia Prevention: Current Evidence
Introduction: Parastomal hernia (PSH) is a common long-term complication following stoma creation. The incidence of PSH exceeds 50% in long-term follow-up of end colostomy patients, while it remains lower in ileostomies and ileal conduit urinary diversions. PSH prevention strategies are of interest due to the poor outcomes and high recurrence rates associated with PSH repair.Overview of Techniques to Prevent PSH: Various technical approaches have been explored to reduce the risk of PSH. However, none have shown consistent benefit toward reducing PSH rate without the use of prophylactic mesh. The keyhole mesh technique was the first to demonstrate a significant reduction in PSH rates in early trials, but larger randomized controlled trials (RCTs) have later questioned its efficacy. The modified keyhole technique, using a funnel-shaped mesh, has shown promising results in recent small studies, with lower PSH incidence and potentially reduced stomal prolapse rate. Other methods such as the Sugarbaker technique and use of biological meshes in PSH prevention have been evaluated as well, with mixed results. While most research focuses on end colostomy, there is limited data on PSH prevention in ileostomies and ileal conduits.Conclusion: Despite early enthusiasm, the keyhole technique has not proven to be effective in preventing PSH. The modified funnel-shaped mesh appears to be a promising development, though long-term outcomes are lacking. Preventive mesh placement is still supported by international guidelines; however, these recommendations are not widely followed in colorectal surgery departments. Thus, further research is essential to guide future recommendations for PSH prevention.
- 7 November 2023
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 111 (1)
Prevention of incisional hernia with retrorectus synthetic mesh versus biological mesh following loop ileostomy closure (Preloop trial)
The rate of incisional hernia after closure of a temporary loop ileostomy is significant. Synthetic meshes are still commonly avoided in contaminated wounds. The Preloop trial was a multicentre RCT designed to evaluate the benefits of synthetic mesh in incisional hernia prevention, and its safety for use in a contaminated surgical site compared with biological mesh. Study patients who underwent closure of a loop ileostomy after anterior resection for rectal cancer were assigned to receive either retrorectus synthetic or biological mesh to prevent incisional hernia. The primary outcomes were surgical-site infections within 30 days, and clinical or radiological incisional hernia incidence at 10 months. Secondary outcomes were reoperation rate, operating time, duration of hospital stay, other complications within 30 days of surgery, 5-year quality of life measured by RAND-36, and incisional hernia incidence within 5 years of follow-up. Between November 2018 and September 2021, 102 patients were randomised, of whom 97 received the intended allocation. At 10-month follow-up, 90 patients had undergone clinical evaluation and 88 radiological evaluation. One patient in each group (2 per cent) had a clinical diagnosis of incisional hernia (P = 0.950) and one further patient in each group had a CT-confirmed incisional hernia (P = 0.949). The number of other complications, reoperation rate, operating time, and duration of hospital stay did not differ between the study groups. Synthetic mesh appeared comparable to biological mesh in efficacy and safety for incisional hernia prevention at the time of loop ileostomy closure. NCT03445936 (http://www.clinicaltrials.gov).
- 7 November 2023
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 111 (1)
Prevention of incisional hernia with retrorectus synthetic mesh versus biological mesh following loop ileostomy closure (Preloop trial)
The rate of incisional hernia after closure of a temporary loop ileostomy is significant. Synthetic meshes are still commonly avoided in contaminated wounds. The Preloop trial was a multicentre RCT designed to evaluate the benefits of synthetic mesh in incisional hernia prevention, and its safety for use in a contaminated surgical site compared with biological mesh. Study patients who underwent closure of a loop ileostomy after anterior resection for rectal cancer were assigned to receive either retrorectus synthetic or biological mesh to prevent incisional hernia. The primary outcomes were surgical-site infections within 30 days, and clinical or radiological incisional hernia incidence at 10 months. Secondary outcomes were reoperation rate, operating time, duration of hospital stay, other complications within 30 days of surgery, 5-year quality of life measured by RAND-36, and incisional hernia incidence within 5 years of follow-up. Between November 2018 and September 2021, 102 patients were randomised, of whom 97 received the intended allocation. At 10-month follow-up, 90 patients had undergone clinical evaluation and 88 radiological evaluation. One patient in each group (2 per cent) had a clinical diagnosis of incisional hernia (P = 0.950) and one further patient in each group had a CT-confirmed incisional hernia (P = 0.949). The number of other complications, reoperation rate, operating time, and duration of hospital stay did not differ between the study groups. Synthetic mesh appeared comparable to biological mesh in efficacy and safety for incisional hernia prevention at the time of loop ileostomy closure. NCT03445936 (http://www.clinicaltrials.gov).
- Open Access
- 27 March 2023
- Published by Springer Nature in BMC Surgery
- Vol. 23 (1) , 1-6
Synthetic mesh versus biological mesh to prevent incisional hernia after loop-ileostomy closure: a randomized feasibility trial
Background: Incisional hernia is a frequent complication after loop-ileostomy closure, rationalizing hernia prevention. Biological meshes have been widely used in contaminated surgical sites instead of synthetic meshes in fear of mesh related complications. However, previous studies on meshes does not support this practice. The aim of Preloop trial was to study the safety and efficacy of synthetic mesh compared to a biological mesh in incisional hernia prevention after loop-ileostomy closure. Methods: The Preloop randomized, feasibility trial was conducted from April 2018 until November 2021 in four hospitals in Finland. The trial enrolled 102 patients with temporary loop-ileostomy after anterior resection for rectal cancer. The study patients were randomized 1:1 to receive either a light-weight synthetic polypropylene mesh (Parietene Macro™, Medtronic) (SM) or a biological mesh (Permacol™, Medtronic) (BM) to the retrorectus space at ileostomy closure. The primary end points were rate of surgical site infections (SSI) at 30-day follow-up and incisional hernia rate during 10 months’ follow-up period. Results: Of 102 patients randomized, 97 received the intended allocation. At 30-day follow-up, 94 (97%) patients were evaluated. In the SM group, 1/46 (2%) had SSI. Uneventful recovery was reported in 38/46 (86%) in SM group. In the BM group, 2/48 (4%) had SSI (p > 0.90) and in 43/48 (90%) uneventful recovery was reported. The mesh was removed from one patient in both groups (p > 0.90). Conclusions: Both a synthetic mesh and biological mesh were safe in terms of SSI after loop-ileostomy closure. Hernia prevention efficacy will be published after the study patients have completed the 10 months’ follow-up.
- 27 March 2023
- Published by Springer Nature in BMC Surgery
- Vol. 23 (1) , 1-6
Open AccessSynthetic mesh versus biological mesh to prevent incisional hernia after loop-ileostomy closure: a randomized feasibility trial
Background: Incisional hernia is a frequent complication after loop-ileostomy closure, rationalizing hernia prevention. Biological meshes have been widely used in contaminated surgical sites instead of synthetic meshes in fear of mesh related complications. However, previous studies on meshes does not support this practice. The aim of Preloop trial was to study the safety and efficacy of synthetic mesh compared to a biological mesh in incisional hernia prevention after loop-ileostomy closure. Methods: The Preloop randomized, feasibility trial was conducted from April 2018 until November 2021 in four hospitals in Finland. The trial enrolled 102 patients with temporary loop-ileostomy after anterior resection for rectal cancer. The study patients were randomized 1:1 to receive either a light-weight synthetic polypropylene mesh (Parietene Macro™, Medtronic) (SM) or a biological mesh (Permacol™, Medtronic) (BM) to the retrorectus space at ileostomy closure. The primary end points were rate of surgical site infections (SSI) at 30-day follow-up and incisional hernia rate during 10 months’ follow-up period. Results: Of 102 patients randomized, 97 received the intended allocation. At 30-day follow-up, 94 (97%) patients were evaluated. In the SM group, 1/46 (2%) had SSI. Uneventful recovery was reported in 38/46 (86%) in SM group. In the BM group, 2/48 (4%) had SSI (p > 0.90) and in 43/48 (90%) uneventful recovery was reported. The mesh was removed from one patient in both groups (p > 0.90). Conclusions: Both a synthetic mesh and biological mesh were safe in terms of SSI after loop-ileostomy closure. Hernia prevention efficacy will be published after the study patients have completed the 10 months’ follow-up.
- Open Access
- 2 September 2022
- Published by Springer Nature in BMC Nutrition
- Vol. 8 (1) , 1-11
Perioperative oral nutritional support for patients diagnosed with primary colon adenocarcinoma undergoing radical surgical procedures -Peri-Nutri Trial: study protocol for a randomized controlled trial
Background: Colon cancer is one of the most common cancers in Finland and worldwide. Cancer-related malnutrition is a well-known risk factor for increased morbidity and mortality after surgery, and it is associated with complications and longer hospitalizations. There are no established recommendations on how to improve the nutritional status of colon cancer patients´ during the perioperative phase. Administration of simple oral nutritional supplements has been suggested to reduce complication rates, but evidence to support this practice is scarce. Methods: The Peri-Nutri trial is a prospective, multicenter, randomized, controlled trial. Its primary endpoint is to evaluate whether perioperative oral nutritional support (ONS) decreases the number of complications during the 30-day follow-up after surgery. Secondary endpoints are to study the effect of ONS on quality of life after surgery, length of stay in institutional care, 90-day mortality rate, five-year disease-free survival and overall survival. The patients with a Nutritional risk screening 2002 (NRS-2002) questionnaire result between 2 and 5 (≥ 3 are classified at risk of malnutrition) will be randomized (1:1 ratio) into either the intervention or control group. The intervention group will receive preoperative ONS two weeks before the operation, and nutritional support will continue 10 days after the operation. The control group will not receive ONS. A total of 318 patients will be randomized into two groups and patients are followed five years. Discussion: Peri-Nutri study evaluate the impact of ONS to short-term and long-term postoperative morbidity and mortality rates of colon cancer patients undergoing curative surgery. If ONS will decrease patients´ morbidity and mortality, that has a huge impact on patients´ quality of life and also to financial cost. Trial registration: ClinicalTrials.gov, NCT03863236, Registered 25 February 2019.
- 2 September 2022
- Published by Springer Nature in BMC Nutrition
- Vol. 8 (1) , 1-11
Open AccessPerioperative oral nutritional support for patients diagnosed with primary colon adenocarcinoma undergoing radical surgical procedures -Peri-Nutri Trial: study protocol for a randomized controlled trial
Background: Colon cancer is one of the most common cancers in Finland and worldwide. Cancer-related malnutrition is a well-known risk factor for increased morbidity and mortality after surgery, and it is associated with complications and longer hospitalizations. There are no established recommendations on how to improve the nutritional status of colon cancer patients´ during the perioperative phase. Administration of simple oral nutritional supplements has been suggested to reduce complication rates, but evidence to support this practice is scarce. Methods: The Peri-Nutri trial is a prospective, multicenter, randomized, controlled trial. Its primary endpoint is to evaluate whether perioperative oral nutritional support (ONS) decreases the number of complications during the 30-day follow-up after surgery. Secondary endpoints are to study the effect of ONS on quality of life after surgery, length of stay in institutional care, 90-day mortality rate, five-year disease-free survival and overall survival. The patients with a Nutritional risk screening 2002 (NRS-2002) questionnaire result between 2 and 5 (≥ 3 are classified at risk of malnutrition) will be randomized (1:1 ratio) into either the intervention or control group. The intervention group will receive preoperative ONS two weeks before the operation, and nutritional support will continue 10 days after the operation. The control group will not receive ONS. A total of 318 patients will be randomized into two groups and patients are followed five years. Discussion: Peri-Nutri study evaluate the impact of ONS to short-term and long-term postoperative morbidity and mortality rates of colon cancer patients undergoing curative surgery. If ONS will decrease patients´ morbidity and mortality, that has a huge impact on patients´ quality of life and also to financial cost. Trial registration: ClinicalTrials.gov, NCT03863236, Registered 25 February 2019.
- Open Access
- 24 June 2022
- Published by SAGE Publications in Scandinavian Journal of Surgery
- Vol. 111 (2)
Incidence of parastomal and incisional hernia following emergency surgery for Hinchey III-IV diverticulitis: A systematic review
Purpose: The aim of this systematic review was to evaluate the risk of parastomal (PSH) and incisional hernias (IH) after emergency surgery for Hinchey III–IV diverticulitis, with comparison between the Hartmann procedure and other surgical techniques. Methods: The Cochrane Library, Embase, PubMed (MEDLINE), Web of Science and Scopus databases were systematically searched. The primary endpoint was parastomal hernia incidence. The secondary endpoint was incisional hernia incidence. Results: Five studies (four randomized controlled trials and one retrospective cohort) with a total of 699 patients were eligible for inclusion. The PSH rate was 15%–46% for Hartmann procedure, 0%–85% for primary anastomosis, 4% for resection, and 2% for laparoscopic lavage. The IH rates were 5%–38% for Hartmann procedure, 5%–27% for primary anastomosis, 9%–12% for primary resection, and 3%–11% for laparoscopic lavage. Conclusions: Both the parastomal and incisional hernia incidences are poorly evaluated and reported, and varied greatly between the studies.
- 24 June 2022
- Published by SAGE Publications in Scandinavian Journal of Surgery
- Vol. 111 (2)
Open AccessIncidence of parastomal and incisional hernia following emergency surgery for Hinchey III-IV diverticulitis: A systematic review
Purpose: The aim of this systematic review was to evaluate the risk of parastomal (PSH) and incisional hernias (IH) after emergency surgery for Hinchey III–IV diverticulitis, with comparison between the Hartmann procedure and other surgical techniques. Methods: The Cochrane Library, Embase, PubMed (MEDLINE), Web of Science and Scopus databases were systematically searched. The primary endpoint was parastomal hernia incidence. The secondary endpoint was incisional hernia incidence. Results: Five studies (four randomized controlled trials and one retrospective cohort) with a total of 699 patients were eligible for inclusion. The PSH rate was 15%–46% for Hartmann procedure, 0%–85% for primary anastomosis, 4% for resection, and 2% for laparoscopic lavage. The IH rates were 5%–38% for Hartmann procedure, 5%–27% for primary anastomosis, 9%–12% for primary resection, and 3%–11% for laparoscopic lavage. Conclusions: Both the parastomal and incisional hernia incidences are poorly evaluated and reported, and varied greatly between the studies.
- Open Access
- 24 June 2022
- Published by Oxford University Press (OUP) in BJS Open
- Vol. 6 (3)
Open versus robotic-assisted laparoscopic posterior component separation in complex abdominal wall repair
Transversus abdominis release (TAR) is a surgical technique used in the treatment of complex ventral hernias. The aim of this study was to compare outcomes of open (oTAR) versus robotic-assisted (rTAR) posterior component separation by TAR. Consecutive patients at two European hernia centres who underwent bilateral TAR were included. The primary endpoint was the duration of postoperative hospital stay. Data from 90 rTAR and 79 oTAR operations were evaluated. Patient demographics were similar between groups in terms of age, sex, BMI, and co-morbidities. There were more smokers, and hernias were larger in the oTAR group (width 8.7 cm versus 10.0 cm; P = 0.031, length 11.6 cm versus 14.1 cm; P = 0.005). Duration of postoperative hospital stay was significantly shorter in the rTAR group (3.4 days versus 6.9 days; P < 0.001). Short-term serious complications (Clavien–Dindo grade III and above) were more frequent (20.3 per cent versus 7.8 per cent; P = 0.018), and there were more surgical site infections (12.7 per cent versus 3.3 per cent; P = 0.010) in the oTAR group. During a median follow-up of 19 months in the rTAR group and 43 months in the oTAR group, reoperation (4.4 per cent versus 8.9 per cent; P = 0.245), and recurrence rates (5.6 per cent versus 5.1 per cent; P > 0.009) were similar. Patients with ventral incisional hernias who undergo bilateral rTAR had significantly shorter postoperative hospital stays and fewer short-term complications compared with patients undergoing bilateral oTAR.
- 24 June 2022
- Published by Oxford University Press (OUP) in BJS Open
- Vol. 6 (3)
Open AccessOpen versus robotic-assisted laparoscopic posterior component separation in complex abdominal wall repair
Transversus abdominis release (TAR) is a surgical technique used in the treatment of complex ventral hernias. The aim of this study was to compare outcomes of open (oTAR) versus robotic-assisted (rTAR) posterior component separation by TAR. Consecutive patients at two European hernia centres who underwent bilateral TAR were included. The primary endpoint was the duration of postoperative hospital stay. Data from 90 rTAR and 79 oTAR operations were evaluated. Patient demographics were similar between groups in terms of age, sex, BMI, and co-morbidities. There were more smokers, and hernias were larger in the oTAR group (width 8.7 cm versus 10.0 cm; P = 0.031, length 11.6 cm versus 14.1 cm; P = 0.005). Duration of postoperative hospital stay was significantly shorter in the rTAR group (3.4 days versus 6.9 days; P < 0.001). Short-term serious complications (Clavien–Dindo grade III and above) were more frequent (20.3 per cent versus 7.8 per cent; P = 0.018), and there were more surgical site infections (12.7 per cent versus 3.3 per cent; P = 0.010) in the oTAR group. During a median follow-up of 19 months in the rTAR group and 43 months in the oTAR group, reoperation (4.4 per cent versus 8.9 per cent; P = 0.245), and recurrence rates (5.6 per cent versus 5.1 per cent; P > 0.009) were similar. Patients with ventral incisional hernias who undergo bilateral rTAR had significantly shorter postoperative hospital stays and fewer short-term complications compared with patients undergoing bilateral oTAR.
- Open Access
- 9 May 2022
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (9) , 2656
Sarcopenia and Myosteatosis Are Associated with Neutrophil to Lymphocyte Ratio but Not Glasgow Prognostic Score in Colorectal Cancer Patients
Cancer patients commonly present sarcopenia, myosteatosis, and systemic inflammation, which are risk factors of poor survival. In this study, sarcopenia and myosteatosis were defined from preoperative body computed tomography scans of 222 colorectal cancer (CRC) patients and analyzed in relation to tumor and patient characteristics, markers of systemic inflammation (modified Glasgow prognostic score (mGPS), neutrophil–lymphocyte ratio (NLR), serum levels of C-reactive protein (CRP), albumin, and 13 cytokines, and survival. Of the systemic inflammation markers, sarcopenia and/or myosteatosis associated with elevated NLR (p = 0.005) and low albumin levels (≤35 g/L) (p = 0.018), but not with mGPS or serum cytokine levels. In addition, myosteatosis was associated with a proximal tumor location (p = 0.039), serrated tumor subtype (p < 0.001), and severe comorbidities (p = 0.004). Multivariable analyses revealed that severe comorbidities and serrated histology were independent predictors of myosteatosis, and older age and elevated NLR were independent indicators of sarcopenia. Myosteatosis associated with shorter overall survival in univariable analysis (HR 1.959, 95% CI 1.24–3.10, p = 0.004) but not in multivariable analysis (p = 0.075). We conclude that sarcopenia and myosteatosis were associated with inflammatory marker NLR, but not with mGPS. Moreover, patients with serrated CRC may have an increased risk of myosteatosis. Myosteatosis or sarcopenia were not independent predictors of patient survival.
- 9 May 2022
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (9) , 2656
Open AccessSarcopenia and Myosteatosis Are Associated with Neutrophil to Lymphocyte Ratio but Not Glasgow Prognostic Score in Colorectal Cancer Patients
Cancer patients commonly present sarcopenia, myosteatosis, and systemic inflammation, which are risk factors of poor survival. In this study, sarcopenia and myosteatosis were defined from preoperative body computed tomography scans of 222 colorectal cancer (CRC) patients and analyzed in relation to tumor and patient characteristics, markers of systemic inflammation (modified Glasgow prognostic score (mGPS), neutrophil–lymphocyte ratio (NLR), serum levels of C-reactive protein (CRP), albumin, and 13 cytokines, and survival. Of the systemic inflammation markers, sarcopenia and/or myosteatosis associated with elevated NLR (p = 0.005) and low albumin levels (≤35 g/L) (p = 0.018), but not with mGPS or serum cytokine levels. In addition, myosteatosis was associated with a proximal tumor location (p = 0.039), serrated tumor subtype (p < 0.001), and severe comorbidities (p = 0.004). Multivariable analyses revealed that severe comorbidities and serrated histology were independent predictors of myosteatosis, and older age and elevated NLR were independent indicators of sarcopenia. Myosteatosis associated with shorter overall survival in univariable analysis (HR 1.959, 95% CI 1.24–3.10, p = 0.004) but not in multivariable analysis (p = 0.075). We conclude that sarcopenia and myosteatosis were associated with inflammatory marker NLR, but not with mGPS. Moreover, patients with serrated CRC may have an increased risk of myosteatosis. Myosteatosis or sarcopenia were not independent predictors of patient survival.